Marked cerebral atrophy is correlated with kidney dysfunction in nondisabled adults
暂无分享,去创建一个
Hideo Hara | Makoto Eriguchi | Masashi Nishihara | K. Node | Y. Nanri | M. Hara | Koichi Node | Y. Yakushiji | Megumi Hara | Yusuke Yakushiji | Yusuke Nanri | Tatsumi Hirotsu | Junko Nakajima | Masanori Nishiyama | H. Hara | M. Nishihara | M. Eriguchi | Masanori Nishiyama | T. Hirotsu | J. Nakajima
[1] K. Nakashima,et al. [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[2] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[3] L. Kuller,et al. Statins and cognitive function in the elderly , 2005, Neurology.
[4] R. Toto,et al. Slowing chronic kidney disease progression: results of prospective clinical trials in adults , 2008, Pediatric Nephrology.
[5] C. DeCarli,et al. Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) , 2007, Stroke.
[6] Carole Dufouil,et al. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. , 2004, Diabetes.
[7] H. Bokura,et al. Subcortical silent brain infarction as a risk factor for clinical stroke. , 1997, Stroke.
[8] Wiro J Niessen,et al. Kidney Function Is Related to Cerebral Small Vessel Disease , 2008, Stroke.
[9] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.
[10] E. B. Larson,et al. Statin Therapy Is Associated with Reduced Neuropathologic Changes Statin Therapy Is Associated with Reduced Neuropathologic Changes of Alzheimer Disease , 2022 .
[11] P. Stenvinkel,et al. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Homocysteine‐Lowering Is Not a Primary Target for Cardiovascular Disease Prevention in Chronic Kidney Disease Patients , 2007, Seminars in dialysis.
[12] Gary A. Ford,et al. Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure , 2007, Journal of Neurology.
[13] Michael F O'Rourke,et al. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.
[14] S. Levine,et al. Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects , 2002, Journal of neurology, neurosurgery, and psychiatry.
[15] Takeo Kato,et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects , 2007, Journal of the Neurological Sciences.
[16] L. Fried,et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. , 1998, Stroke.
[17] L. Allegri,et al. Hypertension as an Etiopathological Factor in the Development of Cerebral Atrophy in Hemodialyzed Patients , 1999, Nephron.
[18] Y. Nanri,et al. Brain Microbleeds and Global Cognitive Function in Adults Without Neurological Disorder , 2008, Stroke.
[19] C. Thompson,et al. Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. , 2009, Stroke.
[20] A Hofman,et al. Homocysteine and brain atrophy on MRI of non-demented elderly. , 2003, Brain : a journal of neurology.
[21] P. Matthews,et al. Risk factors for progression of brain atrophy in aging , 2005, Neurology.
[22] R B D'Agostino,et al. Stroke risk profile, brain volume, and cognitive function , 2004, Neurology.
[23] Charles E. McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[24] Yasuhiko Tomino,et al. Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] Nick Bryan,et al. Clinical Correlates of Ventricular and Sulcal Size on Cranial Magnetic Resonance Imaging of 3,301 Elderly People , 1999, Neuroepidemiology.
[26] G. Alexander,et al. Interactive effects of age and hypertension on volumes of brain structures. , 1997, Stroke.
[27] M. Woodward,et al. Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy , 2005, Circulation.
[28] Deeb N Salem,et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.
[29] C. Jack,et al. Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships , 2008, Journal of the Neurological Sciences.
[30] P. Sandercock,et al. Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.
[31] Anne Newman,et al. Cystatin C and subclinical brain infarction. , 2005, Journal of the American Society of Nephrology : JASN.
[32] D. Siscovick,et al. Alcohol Consumption and Subclinical Findings on Magnetic Resonance Imaging of the Brain in Older Adults: The Cardiovascular Health Study , 2001, Stroke.
[33] J. Spence. Preventing dementia by treating hypertension and preventing stroke. , 2004, Hypertension.
[34] G. Ratcliff,et al. Sex differences in brain aging: a quantitative magnetic resonance imaging study. , 1998, Archives of neurology.
[35] T. Ohtake,et al. Asymptomatic cerebral lacunae in patients with chronic kidney disease. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] Albert Hofman,et al. Cognitive Correlates of Ventricular Enlargement and Cerebral White Matter Lesions on Magnetic Resonance Imaging: The Rotterdam Study , 1994, Stroke.
[37] H. Kraemer,et al. Ethnic and Socioeconomic Differences in Cardiovascular Disease Risk Factors: Findings for Women From the Third National Health and Nutrition Examination Survey, 1988-1994 , 1999 .
[38] Jiang He,et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.
[39] Yasuo Terayama,et al. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia , 1999, International journal of geriatric psychiatry.